---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-361726"
form_type: "8-K"
ticker: "STE"
cik: "0001757898"
company_name: "STERIS plc"
filed_at: "2021-12-20T23:59:59+00:00"
generated_at: "2026-06-27T23:46:16.968185+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# STERIS to sell Renal Care business to Evoqua Water Technologies for ~$196M cash

## Summary
- Cash consideration of approximately $196 million, subject to customary working capital and other adjustments.
- Transaction expected to close in Q1 2022, subject to regulatory review and customary closing conditions.
- Proceeds to be used to pay down debt.
- Renal Care business was acquired as part of the Cantel Medical transaction in June 2021.

## SEC filing metadata
- accession: 0001193125-21-361726
- form_type: 8-K
- ticker: STE
- cik: 0001757898
- company_name: STERIS plc
- filed_at: 2021-12-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1757898/000119312521361726/0001193125-21-361726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1757898/000119312521361726/d243881d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-361726
- JSON: https://secwatch.observer/filing/0001193125-21-361726.json
- Plain text: https://secwatch.observer/filing/0001193125-21-361726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.